Home
 /
Papers
 /
Molecular Biology
 /
High-resolution spatial mapping of cell state and lineage dynamics in vivo with PEtracer
Preprint
Open access
V1
Top 1% · Validated by QED

High-resolution spatial mapping of cell state and lineage dynamics in vivo with PEtracer

Luke W. Koblan, Kathryn E. Yost, Pu Zheng +13 more
June 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.06.15.659774
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Molecular Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By making lineage marks simultaneously readable by sequencing and spatial imaging, PEtracer unlocks in situ phylogenetics—revealing, in a metastasis model, that heritable transcriptional modules and spatial position jointly determine tumor fitness.

QED claims analysis

Summary

PEtracer, a prime editing-based evolving lineage tracing system, enables accurate phylogenetic reconstruction of tens of thousands of cells through installation of eight balanced, predefined lineage marks that are compatible with both single-cell sequencing and high-resolution spatial transcriptomic imaging, revealing that metastatic tumor growth is driven by spatially organized fitness gradients where cancer cells at the lung-tumor interface achieve heritable high-fitness states through integration of cell-intrinsic gene expression programs (Cldn4, Fgf1/Fgfbp1) with permissive microenvironmental signals.

See full analysis
Main Claim 1 –

Eight balanced lineage marks optimize phylogeny reconstruction accuracy

Supporting evidence

  • Prime editing installs predefined 5-nt marks at 56–66% efficiency
  • 5-nt lineage mark screen yields balanced, imaging-compatible sequences
  • Protospacer mismatches tune PEtracer editing rates across timescales
Main Claim 2 –

PEtracer enables high-accuracy sequencing and imaging lineage readout

Main Claim 3 –

PEtracer phylogenies match static barcodes with near-perfect accuracy

Supporting evidence

  • Accurate reconstruction requires >20 edit sites and >60% detection
  • Imaging-based phylogenies correlate lineage proximity with spatial proximity
Main Claim 4 –

MERFISH maps 18 tumor microenvironment cell types by boundary location

Abstract

Charting the spatiotemporal dynamics of cell fate determination in development and disease is a long-standing objective in biology. Here we present the design, development, and extensive validation of PEtracer, a prime editing-based, evolving lineage tracing technology compatible with both single-cell sequencing and multimodal imaging methodologies to jointly profile cell state and lineage in dissociated cells or while preserving cellular context in tissues with high spatial resolution. Using PEtracer coupled with MERFISH spatial transcriptomic profiling in a syngeneic mouse model of tumor metastasis, we reconstruct the growth of individually-seeded tumors in vivo and uncover distinct modules of cell-intrinsic and cell-extrinsic factors that coordinate tumor growth. More generally, PEtracer enables systematic characterization of cell state and lineage relationships in intact tissues over biologically-relevant temporal and spatial scales.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?